Edgewise Therapeutics Inc. Soared
Fri, Jan 19, 2024 at 07:20 PM
Edgewise Therapeutics Inc. (EWTX:NASDAQ) jumped higher at $13.04, a gain of 34.6%. On Fri, Jan 19, 2024, EWTX:NASDAQ hit a New 2-Week High of $13.04. The stock appeared on our News Catalysts scanner on Tue, Jan 16, 2024 at 11:37 AM in the 'MISCELLANEOUS' category. From Fri, Jan 05, 2024, the stock recorded 66.67% Up Days and 70.00% Green Days
About Edgewise Therapeutics Inc. (EWTX:NASDAQ)
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 300%
- Kaman Corporation (KAMN:NYSE), 100.85%
- Mesa Air Group, Inc. (MESA:NASDAQ), 49.98%
- Edgewise Therapeutics Inc. (EWTX:NASDAQ), 34.57%
- Salem Media Group, Inc. (SALM:NASDAQ), 30.32%
- Tricon Residential Inc. (TCN:NYSE), 28.27%
- Gamida Cell Ltd. (GMDA:NASDAQ), 27.04%
- ProMIS Neurosciences Inc. (PMN:NASDAQ), 27.01%
- micromobility.com Inc Cl A (MCOM:NASDAQ), 26.9%
- Palatin Technologies, Inc. (PTN:NYSEMKT), 26.03%